RED:BMERedeia Corporacion SA Analysis
Data as of 2026-03-14 - not real-time
$15.86
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Red Cat Holdings is trading in a bullish technical environment – the price sits above the 20‑day (≈13.67) and 50‑day (≈13.29) SMAs, the 14‑day RSI is in the low 60s, and the MACD line sits comfortably above its signal line with a positive histogram, all reinforced by an increasing volume trend. The stock is priced near the upper end of its 52‑week range (current ≈15.86 vs. resistance ≈18.78) and enjoys a 30% upside potential according to the computed upside/downside metric, while the Fear & Greed Index reads “Greed” at 72.9, indicating strong market appetite; recent headlines note new Black Widow drone orders from an Asia‑Pacific ally and the launch of a 2× leveraged ETF (RCAX) that could amplify buying pressure.
Fundamentally, the company is struggling – gross margin is deeply negative, operating margins are below –180%, and cash flow is out of sync with a sizable cash pile and a high debt‑to‑equity ratio of roughly 9. No dividend is paid, and valuation multiples (negative PE, P/B ≈7.4, price‑to‑sales >250) suggest the shares are overvalued relative to earnings and book value. Volatility is extreme (>112% 30‑day) and beta exceeds 2, flagging substantial market risk, while regulatory and geopolitical exposure in the defense sector adds further uncertainty.
Fundamentally, the company is struggling – gross margin is deeply negative, operating margins are below –180%, and cash flow is out of sync with a sizable cash pile and a high debt‑to‑equity ratio of roughly 9. No dividend is paid, and valuation multiples (negative PE, P/B ≈7.4, price‑to‑sales >250) suggest the shares are overvalued relative to earnings and book value. Volatility is extreme (>112% 30‑day) and beta exceeds 2, flagging substantial market risk, while regulatory and geopolitical exposure in the defense sector adds further uncertainty.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover and positive histogram
- RSI in the 60s indicating sustained momentum
- Rising trading volume supporting price advance
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong sector tailwinds from geopolitical tensions
- Launch of a 2× leveraged ETF increasing investor exposure
- Support level at $10.80 providing downside cushion
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Negative profitability and cash‑flow trends
- High debt‑to‑equity ratio and leverage risk
- Valuation metrics (negative PE, high P/B) suggest overvaluation
Key Metrics & Analysis
Financial Health
Revenue Growth646.40%
P/E Ratio-52.9
Debt/Equity8.85
P/B Ratio7.4
Op. Cash Flow$-68693328
Industry P/E29.1
Technical Analysis
TrendBullish
RSI60.7
Support$10.80
Resistance$18.78
MA 20$13.67
MA 50$13.29
MA 200$10.20
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price$20.75
Upside/Downside30.83%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.38
Volatility112.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.